Amanda Adler

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (9)

Julian Griffin

University of Aberdeen

UNITED KINGDOM

View details

Charalambos Antoniades

University of Oxford

UNITED KINGDOM

View details

James Buchanan

Queen Mary University of London

UNITED KINGDOM

View details

Richard Grieve

Professor

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

Kamlesh Khunti

University of Leicester Diabetes Research Centre

UNITED KINGDOM

View details

Richard Silverwood

University College London

UNITED KINGDOM

View details

Ruth Coleman

University of Oxford

UNITED KINGDOM

View details

Jack Miller

Aarhus University

DENMARK

View details

Liz Morrell

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amanda Adler

Research Interests

Explore related searches

Contact this professor

Articles (11)

Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data

Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use

Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).

Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.

Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus

Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial

Live to eat and eat to live longer

Endpoints and estimands: understanding trials of weight-loss drugs

Extrapolation beyond the end of trials to estimate long term survival and cost effectiveness

Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study

Nintedanib for treating progressive fibrosing interstitial lung diseases.

Collaborators (9)

Julian Griffin

Charalambos Antoniades

James Buchanan

Richard Grieve

Kamlesh Khunti

Richard Silverwood

Ruth Coleman

Jack Miller

Liz Morrell

Make your next move.